Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 in Juvenile Idiopathic Arthritis
NCT05871086Phase 3Unknown
- Start
- May 2023
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in juvenile idiopathic arthritis (JIA). Primary endpoint: Disease Activity Evaluation at 3 months. Status: unknown.
02
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on NCT05871086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05871086.